PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation

Area of Science:

• Biochemistry
• Dermatology
• Cell Biology

Background:

• Melanogenesis, the process of melanin production, is tightly regulated by various signaling pathways.
• Extracellular signal-related kinase (ERK) activation has been implicated in hypopigmentation.
• Sphingosylphosphorylcholine (SPC) is a bioactive lipid mediator with diverse cellular functions.

Purpose of the Study:

• To investigate the molecular mechanisms by which SPC induces hypopigmentation.
• To elucidate the roles of ERK, protein phosphatase 2A (PP2A), and DUSP6 in SPC-mediated melanogenesis.
• To determine if PP2A inhibition contributes to SPC-induced hypopigmentation.

Main Methods:

• Mel-Ab cells were treated with SPC and PD98059 (ERK inhibitor).
• Protein phosphatase 2A (PP2A) activity was measured.
• Dual-specificity phosphatase 6 (DUSP6) expression levels were analyzed.
• DUSP6 inhibition was performed to assess its effect on ERK activation and hypopigmentation.

Main Results:

• SPC activated ERK, and PD98059 reversed SPC-induced hypopigmentation.
• SPC significantly reduced PP2A activity, which was restored by PP2A activator treatment, abrogating hypopigmentation.
• SPC decreased DUSP6 levels, while α-melanocyte-stimulating hormone (α-MSH) increased DUSP6 expression.
• Inhibition of DUSP6 enhanced ERK activation and augmented SPC-induced hypopigmentation.

Conclusions:

• SPC-induced hypopigmentation is mediated by ERK activation and PP2A inhibition.
• The decrease in DUSP6 expression by SPC contributes to enhanced ERK activation and subsequent hypopigmentation.
• These findings reveal a novel signaling cascade involving SPC, PP2A, DUSP6, and ERK in the regulation of melanogenesis.